recent articles
Aiforia Technologies Plc announces the CE-IVD marking of the Aiforia® Clinical AI Model for Prostate Cancer; Gleason Grade Groups. This latest regulatory certification brings Aiforia’s portfolio of AI-powered diagnostic tools to a total of 5...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing